Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new therapy, especially if you have respiratory conditions, skin disorders, or other health concerns. Halotherapy is not FDA-approved as a medical treatment.
Affiliate Disclosure: Some links in this article may be affiliate links. We may earn a small commission at no extra cost to you if you purchase through these links. This helps support Salt Cave Finder and allows us to continue providing free, research-backed content.
Quick Answer: Long-term halotherapy research is still in its early stages, but the existing evidence paints a cautiously optimistic picture for certain conditions. Studies spanning 6-12 months suggest regular salt cave sessions may improve mucociliary clearance, reduce the frequency of respiratory flare-ups, and modestly improve quality of life scores in asthma and chronic bronchitis patients. However, out of roughly 151 identified studies on halotherapy, only one met rigorous randomized controlled trial standards — meaning the long-term evidence base remains thin. No major medical organization currently endorses halotherapy as a standalone long-term treatment. The most honest summary: promising preliminary data, but not enough high-quality longitudinal research to make definitive claims.
What "Long-Term" Actually Means in Halotherapy Research
Before diving into the data, we need to define what researchers mean by "long-term" when studying halotherapy. And the answer is uncomfortable — most studies are short.
The vast majority of halotherapy research looks at acute effects: what happens during or immediately after a single session or a short series of sessions over 2-4 weeks. True long-term studies — tracking patients over 6 months, a year, or multiple years — are rare. When they exist, they tend to come from Eastern European research institutions where salt therapy has deeper cultural and medical roots, particularly in Poland, Romania, and Ukraine.
A 2014 review published in the Annals of Agricultural and Environmental Medicine examined the significance of salt caves as simulations of natural underground environments, noting that the tradition of therapeutic salt mine visits dates back to the 1840s. Polish physician Feliks Boczkowski first documented that salt miners had significantly lower rates of respiratory disease than the general population — an observation that effectively launched 180+ years of investigation.
But here's the problem with that historical narrative. Observational evidence isn't the same as clinical proof. Salt miners breathing salt-rich air for decades is interesting epidemiology, not a controlled trial. The leap from "miners seemed healthier" to "therefore, weekly 45-minute salt room sessions will improve your lung function long-term" involves assumptions that haven't been rigorously tested.
What we do have: a handful of studies tracking patients through extended treatment protocols (typically 10-20 sessions over several months) and then following up weeks or months later. These give us our best — if limited — window into long-term effects.
For a broader overview of the current evidence landscape, see our Salt Cave Benefits guide.
Respiratory Effects: The Strongest (and Most Studied) Long-Term Evidence
Respiratory health is where halotherapy research is most concentrated. And while the evidence isn't conclusive, it's the closest thing we have to a long-term evidence base.
Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
A study published in Pneumologia reviewed halotherapy's journey "from the cave to the clinical," finding that patients with chronic respiratory disorders who underwent regular halotherapy sessions showed improvements in several measurable parameters:
- FEV1 (forced expiratory volume) improved by 7-15% in some study groups after 10-14 sessions
- Mucociliary clearance — the mechanism by which your airways self-clean — showed measurable improvement during and after treatment courses
- Exacerbation frequency decreased in some COPD patients who continued periodic halotherapy over 6+ months, though these were observational findings
The International Journal of COPD published surveys on therapeutic effects of halotherapy chambers with artificial salt-mine environments. The results showed that patients with chronic allergenic respiratory conditions and infectious-inflammatory pathologies reported reduced symptom severity and improved quality of life after extended treatment protocols.
But the key word is "reported." Most of these studies relied heavily on self-reported outcomes rather than objective lung function measurements over extended periods. And when lung function was measured objectively, the improvements — while statistically significant in some cohorts — were modest compared to standard pharmaceutical interventions.
Asthma
For asthma specifically, a 2021 systematic review found "limited evidence" that halotherapy may aid mucus clearance, improve lung function, and generally improve quality of life in asthmatic patients. The operative word is "limited." The researchers were explicit: larger, high-quality studies were necessary before drawing firm conclusions.
What's interesting from a long-term perspective is the recurrence pattern. Several studies noted that benefits observed during active treatment courses tended to diminish 2-4 months after stopping sessions. This suggests halotherapy's respiratory effects — whatever they are — require ongoing maintenance rather than producing permanent changes. That has implications for both effectiveness claims and cost considerations.
If you're weighing halotherapy against conventional respiratory treatments, our Salt Cave vs Nebulizer comparison breaks down the differences in detail.
Skin Health: Emerging but Underpowered Evidence
The second most-studied area for long-term halotherapy effects is dermatological — specifically eczema, psoriasis, and atopic dermatitis.
The theory is straightforward: aerosolized sodium chloride particles landing on skin may have anti-inflammatory and antimicrobial properties, similar to the well-documented effects of ocean/mineral-rich water on certain skin conditions. Dead Sea therapy (climatotherapy) has a stronger evidence base for psoriasis, and halotherapy advocates argue the mechanism is related.
Here's what the long-term evidence actually shows:
For eczema and atopic dermatitis: A few small studies (generally 30-60 participants) tracked patients through 10-20 halotherapy sessions and then followed up at 3-month and 6-month intervals. Some reported sustained improvement in SCORAD scores (a standardized eczema severity index) at the 3-month mark, but by 6 months, most patients had returned close to baseline. The sample sizes were too small to draw reliable conclusions, and none of these studies were properly blinded.
For psoriasis: Evidence is even thinner. Case reports and small case series exist, but nothing approaching a controlled study of long-term outcomes. The comparison to Dead Sea climatotherapy is appealing but scientifically lazy — the mineral composition, UV exposure, and environmental conditions of Dead Sea therapy are fundamentally different from sitting in a salt room with a halogenerator.
For general skin hydration and appearance: Zero controlled long-term studies. The claims about "improved skin texture" and "anti-aging effects" that you'll see on some facility websites have no published clinical evidence behind them. That doesn't mean people don't feel like their skin looks better after sessions — but subjective satisfaction and measured dermatological improvement are different things.
Facilities like Crystal SPA in Los Angeles often emphasize the skin benefits of their halotherapy sessions. And anecdotally, many regular users report positive skin changes. The research just hasn't caught up to validate (or invalidate) these experiences with proper longitudinal studies.
Stress, Sleep, and Mental Health: The Underresearched Frontier
This is the area where long-term halotherapy research is almost nonexistent — but where regular users report some of the most compelling subjective benefits.
The relaxation component of salt cave therapy is real but hard to disentangle from the therapy itself. Salt caves are quiet, dimly lit, temperature-controlled spaces where you sit still and breathe deeply for 45 minutes. That's essentially a meditation session with a specific ambiance. The question is whether the salt aerosol adds anything beyond what you'd get from simply sitting quietly in a dark room.
Here's what limited data exists:
Cortisol measurements: One small study (n=32) measured salivary cortisol levels before and after halotherapy sessions over a 4-week period. Cortisol dropped significantly post-session, but this finding is meaningless in isolation — cortisol also drops after a nap, a bath, or watching a comforting TV show. No study has tracked cortisol patterns in regular halotherapy users over months or years versus a control group.
Sleep quality: Self-reported sleep quality improvements appear in several halotherapy surveys, but these are consistently confounded by the relaxation environment. No polysomnography (objective sleep monitoring) studies have been conducted in halotherapy populations over any timeframe.
Anxiety and depression scores: A couple of Eastern European studies included standardized anxiety questionnaires (typically the HAM-A or STAI) in their halotherapy research. Scores improved modestly during treatment courses. But again — sitting quietly in a peaceful room for 45 minutes three times a week would likely improve anxiety scores regardless of salt content in the air.
The honest assessment: salt cave environments probably do help with stress and relaxation, but we genuinely don't know whether the salt component contributes to this beyond the environmental/behavioral factors. And nobody has studied whether these effects accumulate or persist over months and years of regular use.
For a full picture of what these sessions involve, our Complete Guide to Salt Caves covers the experience from start to finish.
Safety Profile: What Long-Term Use Might Mean for Your Body
When we talk about long-term effects, safety is just as important as efficacy. And here, the research picture is frustratingly incomplete.
The American Lung Association has noted that halotherapy is "probably safe for most people" but flagged that there are no dedicated safety studies — and that sessions typically occur in spa or wellness settings without trained medical staff available for emergencies.
What the Safety Data Shows
Short-term side effects (well-documented): Approximately 15-20% of halotherapy users report at least one mild side effect during or shortly after sessions. The most common include:
- Throat irritation or cough (the most frequently reported, affecting roughly 1 in 5 first-time users)
- Mild headache
- Temporary skin irritation in people with sensitive skin or open wounds
- Nasal irritation or runny nose
- Eye irritation (particularly if wearing contact lenses)
These effects are generally mild and self-limiting. For a comprehensive breakdown, see our Salt Cave Side Effects guide.
Long-term safety (poorly documented): No published study has systematically tracked adverse effects in regular halotherapy users over periods exceeding 12 months. That's a significant gap. The assumptions of long-term safety are based largely on:
- The historical observation that salt miners didn't develop unusual lung diseases (though they worked in different conditions than modern halotherapy)
- The absence of reported serious adverse events in the existing literature (absence of evidence isn't evidence of absence)
- The fact that sodium chloride is generally recognized as safe (GRAS) by the FDA — though this designation applies to dietary consumption, not chronic inhalation
Populations That Need Extra Caution
Certain groups face higher potential risk from long-term halotherapy use, and the lack of safety data makes this especially concerning:
- People with severe or unstable respiratory conditions: Bronchospasm has been reported in rare cases. Long-term repeated exposure in people with hyperreactive airways hasn't been studied.
- Children under 6 months: No safety data exists. Several facilities set minimum age requirements at 3-6 months, but this is based on industry consensus, not clinical evidence.
- People with active infections: Salt aerosol may irritate inflamed airways. Shared salt rooms present theoretical infection transmission risks, though modern facilities use HEPA filtration.
- People on certain medications: The interaction between chronic salt aerosol inhalation and respiratory medications (inhaled corticosteroids, bronchodilators) over extended periods hasn't been studied.
The Sodium Question
One question that comes up frequently: does breathing salt particles increase your overall sodium intake enough to matter for blood pressure or cardiovascular health?
The short answer is no — at least not at the concentrations used in standard halotherapy (5-25 mg/m³ of air). You'd inhale roughly 0.5-2 mg of sodium chloride per session, which is negligible compared to dietary intake. But this calculation assumes standard halogenerator settings. Facilities operating at higher concentrations, or people attending daily sessions over months, haven't been specifically studied for sodium-related cardiovascular effects.
What Regular Users Actually Report: Anecdotal Evidence vs. Clinical Data
Since long-term clinical research is sparse, it's worth acknowledging what the community of regular halotherapy users consistently reports. Anecdotal evidence isn't proof, but patterns in user experiences can generate hypotheses for future research.
Based on user reviews and surveys from facilities including Valley Salt Cave and Salt Me Halotherapy in the Los Angeles area, along with broader online community forums:
Commonly reported long-term benefits (after 3+ months of regular use):
- Reduced frequency of upper respiratory infections and colds (the most consistently reported benefit)
- Less reliance on antihistamines during allergy seasons
- Improved breathing ease, particularly in the morning
- Better sleep quality
- Reduced skin flare-ups (eczema, psoriasis)
- General stress reduction and "reset" feeling
Commonly reported diminishing returns:
- Many users note the biggest improvements happen in the first 8-12 sessions, with subsequent sessions providing maintenance rather than additional gains
- Some report needing to increase session frequency over time to maintain the same subjective benefit (tolerance or placebo decay — unclear which)
- A minority of users report that initial improvements plateaued and eventually disappeared, leading them to discontinue
The maintenance pattern: The most consistent anecdotal finding aligns with what limited research suggests: benefits require ongoing sessions. Users who stop typically report losing perceived benefits within 1-3 months. This mirrors the clinical finding that mucociliary clearance improvements don't appear to persist indefinitely after treatment cessation.
This "maintenance requirement" pattern is important context for cost considerations. At $35-65 per session (the U.S. average), attending twice weekly adds up to $280-520 per month. Over a year, that's $3,360-6,240 — a significant investment for benefits that remain scientifically unproven. Membership packages at facilities like Crystal SPA can reduce per-session costs significantly, but the annual commitment is still substantial.
The Research Gap: Why Don't We Have Better Long-Term Data?
It's fair to ask: if halotherapy has been around since the 1840s and the modern commercial industry has boomed since the 2010s, why is the long-term research so thin? Several factors explain this:
Funding Problems
Clinical trials are expensive. A properly designed, double-blinded, randomized controlled trial with long-term follow-up for a respiratory intervention could easily cost $2-5 million. Pharmaceutical companies fund most respiratory research because they have products to sell. Halotherapy — using ordinary sodium chloride — isn't patentable. There's no financial incentive for pharma to fund these studies, and the halotherapy industry itself is fragmented among small independent operators without the capital for large-scale research.
Blinding Challenges
How do you create a convincing placebo for a salt cave? Participants know they're in a salt room. Sham comparators (rooms without halogenerators but with salt on the walls) have been used, but participants may notice the difference in air quality. This makes true double-blinding extremely difficult, and unblinded studies are inherently less reliable.
Regulatory Ambiguity
Halotherapy exists in a regulatory gray zone. It's not classified as a medical treatment by the FDA, so it doesn't face the same evidence requirements as pharmaceuticals. But it's also not purely a wellness activity when facilities make specific health claims. This ambiguity means there's no regulatory pressure to generate long-term safety and efficacy data — nobody is requiring it.
Geographic Research Concentration
The strongest halotherapy research tradition is in Eastern Europe, particularly Poland (where salt mine therapy is covered by some health insurance plans) and Romania. Research from these regions is often published in regional journals, may not be available in English, and sometimes uses methodologies that don't meet Western clinical trial standards. Meanwhile, Western academic medical centers have shown limited interest in studying what many consider an "alternative" therapy.
What's Coming
There are some encouraging signs. As of early 2026, at least 3 registered clinical trials on ClinicalTrials.gov are actively investigating halotherapy — including one multicenter trial examining respiratory outcomes over a 12-month period. The Salt Therapy Association has been advocating for more standardized research protocols and has funded some smaller studies. If these trials complete and publish results in the next 2-3 years, we'll have meaningfully better data on long-term effects.
How to Evaluate Long-Term Halotherapy for Yourself
Given the state of the evidence, here's a practical framework for thinking about long-term halotherapy use:
Questions to Ask Before Committing Long-Term
-
What specific outcome am I hoping for? "General wellness" is hard to measure. "Fewer asthma exacerbations per season" is something you can actually track.
-
Am I using this alongside — not instead of — proven treatments? If you have a diagnosed respiratory or skin condition, halotherapy should complement your existing treatment plan, never replace it. Talk to your doctor before starting.
-
Can I afford the ongoing cost? Long-term halotherapy means long-term expense. Calculate the annual cost at your intended frequency and compare it to your budget and to the strength of evidence for your specific condition.
-
Am I tracking my response objectively? Keep a simple log: peak flow readings (if respiratory), symptom frequency, medication use, skin severity scores. This turns your personal experience into useful data — for you and for your healthcare provider.
-
Is the facility using proper equipment? A halogenerator with pharmaceutical-grade salt is non-negotiable. Salt blocks on walls are decor, not therapy. Ask about particle size (1-5 microns is the therapeutic range) and salt concentration (5-25 mg/m³).
A Reasonable Approach
Based on the available evidence and expert opinions aggregated across the literature:
- Try a trial period first: 10-15 sessions over 4-6 weeks. This matches the most common research protocols and gives you enough exposure to notice subjective changes.
- Track your baseline: Note your symptom frequency, medication use, and subjective wellness before starting. Without a baseline, you can't know if anything changed.
- Evaluate honestly at 6 weeks: Did you notice meaningful improvement in your specific target? If not, long-term commitment probably isn't justified for you.
- If continuing, find a sustainable frequency: Most facilities recommend 1-3 sessions per week for maintenance. Start with the minimum and increase only if the response justifies it.
- Reassess every 3 months: Are you still getting value? Has your health situation changed? Are there new evidence-based treatments you should consider?
Frequently Asked Questions
How long do the effects of halotherapy last after you stop going? Based on the limited research available, the effects of halotherapy appear to diminish within 1-4 months after stopping regular sessions. Studies measuring mucociliary clearance found that improvements observed during active treatment courses tended to return toward baseline within 2-4 months of cessation. User reports align with this — most regular halotherapy users note that perceived benefits fade within a few weeks to a few months after stopping. This suggests that whatever mechanisms are at work, they require ongoing exposure rather than producing permanent physiological changes.
Is it safe to do halotherapy every day long-term? No long-term safety study has specifically evaluated daily halotherapy use over extended periods. Most clinical research protocols used 3-5 sessions per week for 2-4 weeks, not daily indefinite use. The primary concern with very frequent, prolonged use would be chronic airway irritation — particularly in people with hyperreactive airways or existing respiratory conditions. Most facilities and the Salt Therapy Association recommend 2-3 sessions per week as a maintenance frequency. If you're considering daily use, discuss it with your physician, especially if you have any respiratory conditions.
Can halotherapy replace my asthma or COPD medications long-term? No. No published research supports halotherapy as a replacement for prescribed respiratory medications. The studies that showed respiratory benefits in asthma and COPD patients were conducted while participants continued their standard medication regimens. The American Lung Association and the Cleveland Clinic have both stated clearly that halotherapy should not substitute for physician-prescribed treatments. Discontinuing prescribed medications based on perceived improvement from halotherapy could be dangerous and potentially life-threatening.
Do children experience different long-term effects from halotherapy than adults? Pediatric halotherapy research is extremely limited. A few small studies included children with respiratory conditions and reported similar short-term improvements to adult populations — primarily reduced cough frequency and improved nasal breathing. However, no study has followed pediatric halotherapy users over periods longer than a few months. Children's developing respiratory systems may respond differently to chronic salt aerosol exposure than adult lungs, and this has not been investigated. Most facilities accept children as young as 3-6 months, but this age guideline is based on industry practice, not clinical safety data.
What does the research say about long-term halotherapy for allergies specifically? The evidence for halotherapy and allergies is largely indirect. Saline nasal irrigation (a mechanistically different treatment) has solid evidence for allergic rhinitis relief. Halotherapy involves breathing aerosolized dry salt, which theoretically could have similar mucosal effects in the upper airways. A few studies have reported reduced allergy symptom scores and decreased antihistamine use during halotherapy treatment courses, but long-term follow-up data (6+ months) is essentially nonexistent. The strongest indirect evidence comes from the surveys in the International Journal of Environmental Research and Public Health showing improvement in patients with "chronic allergenic respiratory pathologies" — but these were short-term observational findings, not long-term controlled studies.
Related Reading
- Salt Caves and Halotherapy Benefits: What the Latest Research Shows [2026] — A broader look at all documented halotherapy benefits and the quality of evidence behind each claim
- Salt Caves and Halotherapy Side Effects and Risks: What You Need to Know [2026] — Comprehensive guide to potential adverse effects and who should avoid halotherapy
- The Complete Guide to Salt Caves and Halotherapy [2026] — Everything you need to know before your first visit, from what to wear to what to expect
-- The Salt Cave Finder Team